Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Injectable Devices Market

Veterinary Injectable Devices Market Analysis

  • Report ID: GMI6053
  • Published Date: Jun 2023
  • Report Format: PDF

Veterinary Injectable Devices Market Analysis

Based on product, the veterinary injectable devices market is segmented into syringes, needles, remote injectable devices, needle free injector systems, auto-injectors, and other injectables devices. In 2022, the syringes segment accounted for the largest share of 29.3% in the industry. The rising trend of pet ownership and the growing awareness of animal health have led to increased demand for veterinary care.
 

As more people bring pets into their families, there is a corresponding need for injectable treatments. Syringes are essential devices for accurately measuring and administering medications to companion animals, driving the demand for syringes in the market. Moreover, the development of specialized syringes for different animal species and treatment requirements, the expansion of veterinary healthcare services, and the increasing emphasis on animal welfare.
 

Veterinary Injectable Devices Market Share, By Material

Based on material, the veterinary injectable devices market is segmented as plastic, metal, glass, and other materials. The plastic segment held dominant market share of around 49.0% in 2022. Plastic materials offer a cost-effective solution for manufacturing veterinary injectable devices. Plastic is generally less expensive than other materials such as metal or glass, making it a preferred choice for mass production. The cost-effectiveness of plastic materials allows for affordable pricing of injectable devices, making them accessible to veterinary professionals and pet owners.
 

Based on usage, the veterinary injectable devices market is segmented as disposable, reusable, and sterile devices. The disposable devices segment held the maximum market revenue of USD 429.9 million in the year 2022 and is expected to grow at a 4.8% by 2032. Factors that collectively contribute to the growing demand for disposable injectable devices in the veterinary industry include the emphasis on high level of safety, minimized risk of infection, convenience and time efficiency for veterinary professionals, and cost-effectiveness.
 

Based on animal type, the veterinary injectable devices market is segmented as companion animals, livestock animal, and other animals. The companion animals segment is expected to grow at a significant pace of 4.8% by 2032. Pet owners are becoming increasingly aware of the importance of preventive care for their companion animals. Vaccinations, parasite control, and routine health check-ups are essential for maintaining the health and well-being of pets. Injectable devices are commonly used in preventive care practices, such as administering vaccines and preventive medications.
 

Based on end user, the veterinary injectable devices market is segmented as veterinary hospitals, veterinary clinics, academic and research institutes, and other end-users. The veterinary clinics segment held a dominant market share of 44% in 2022 and is expected to grow at a CAGR of 5.4% by 2032. The demand for veterinary services is on the rise due to increasing pet ownership, changing demographics, and the growing awareness of pet healthcare. Veterinary clinics are the primary providers of comprehensive medical care for animals, including diagnostics, and treatments. Injectable devices are essential tools for delivering medications, vaccines, anesthetics, and other treatments.
 

North America Veterinary Injectable Devices Market,

North America veterinary injectable devices market is anticipated to grow at 4.7% by 2032. North America has a well-developed veterinary infrastructure, including veterinary practices, hospitals, and clinics. The region has a high concentration of skilled veterinarians and veterinary professionals. This robust veterinary infrastructure supports the use of injectable devices in delivering comprehensive veterinary care.
 

Moreover, there is a strong emphasis on animal health and well-being in North America. Pet owners in the region are highly concerned about the health and quality of life of their pets. This focus on animal health drives the demand for veterinary services and the use of injectable devices to ensure proper medical care and treatment for pets.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for veterinary injectable devices was worth USD 879.1 million in 2022 and is expected to reach USD 1,418.3 million by 2032 driven by the increasing demand for veterinary healthcare and the rising need for disease prevention and management.

The syringes product segment held 29.3% share in the market and is estimated to depict significant growth through 2032 owing to the rising trend of pet ownership and the growing awareness of animal health.

North America industry is poised to grow at 4.7% CAGR from 2023 to 2032 attributed to the presence of well-developed veterinary infrastructure, including veterinary practices, hospitals, and clinics across the region.

Merck & Co., Inc., Hamilton Company, Neogen Corporation, Micrel Medical Devices SA, Serumwerk Bernburg AG, PBS Animal Health, Medtronic plc, Millpledge Pharmaceuticals, Terumo Medical Corporation, and Baxter International Inc. are among the top participants in the industry.

Veterinary Injectable Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 434
  • Countries covered: 19
  • Pages: 251
 Download Free Sample